Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 6Breast 3Thoracic 1Other 1Genitourinary 1

Conditions

Breast Neoplasms 3Hot Flashes 2Pain 1Lung Neoplasms 1

Interventions

Cyclophosphamide 171Docetaxel 164Paclitaxel 160Trastuzumab 152Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Gabapentin × Breast × Clear all
NCT01067144 2022-05-05

Stanford Accelerated Recovery Trial (START)

Stanford University

Phase 3 Terminated
422 enrolled 12 charts
BreastThoracic

Breast Neoplasms, Lung Neoplasms, Pain

NCT00087399 2016-07-14

Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
118 enrolled
Breast

Breast Neoplasms, Hot Flashes

NCT00711529 2013-06-24

Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.

Women and Infants Hospital of Rhode Island

Phase 3 Completed
27 enrolled 13 charts
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡